Your institution may have access to this item. Find your institution then sign in to continue.
Title
An antibiotic comeback?
Abstract
The article reports on the reinvestment made by several biomedical companies including Roche, AstraZeneca, and Sanofi in 2013 to pursue antibiotic research due to growing cases of antibiotic-resistance bacteria.